Appetite-suppressant stops diabetes

A breakthrough twice-a-day weight-loss drug slashes the risk of developing type 2 diabetes by nearly a fifth, a landmark trial has found. Lorcaserin, hailed as the 'holy grail' of weight management, controlled high blood sugar in obese and overweight patients.